COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.
from News Medical Medical Research News Feed https://ift.tt/38CHYgH
0 Comments